Acadia Healthcare Company, Inc. (NASDAQ:ACHC) has earned an average rating of “Hold” from the eighteen analysts that are presently covering the firm, Marketbeat.com reports. Two equities research analysts have rated the stock with a sell recommendation, six have issued a hold recommendation and nine have issued a buy recommendation on the company. The average 12-month price objective among brokers that have issued ratings on the stock in the last year is $45.92.

Several analysts have recently commented on ACHC shares. Cantor Fitzgerald decreased their price objective on shares of Acadia Healthcare from $48.00 to $39.00 and set a “neutral” rating on the stock in a research report on Tuesday, October 24th. William Blair started coverage on shares of Acadia Healthcare in a research report on Tuesday, July 18th. They set an “outperform” rating on the stock. Zacks Investment Research downgraded shares of Acadia Healthcare from a “hold” rating to a “sell” rating in a research report on Thursday, October 12th. Citigroup Inc. decreased their price objective on shares of Acadia Healthcare from $61.00 to $44.00 and set a “buy” rating on the stock in a research report on Wednesday, October 25th. Finally, BMO Capital Markets started coverage on shares of Acadia Healthcare in a research report on Monday, October 16th. They set an “outperform” rating and a $52.00 price objective on the stock.

Acadia Healthcare (NASDAQ ACHC) opened at $29.95 on Monday. The company has a debt-to-equity ratio of 1.30, a quick ratio of 1.36 and a current ratio of 1.36. The stock has a market capitalization of $2,631.22, a price-to-earnings ratio of 13.08, a P/E/G ratio of 1.11 and a beta of 0.89.

Acadia Healthcare (NASDAQ:ACHC) last announced its quarterly earnings data on Tuesday, October 24th. The company reported $0.58 EPS for the quarter, missing the Thomson Reuters’ consensus estimate of $0.65 by ($0.07). The firm had revenue of $716.70 million for the quarter, compared to the consensus estimate of $728.86 million. Acadia Healthcare had a net margin of 6.07% and a return on equity of 8.57%. The firm’s revenue for the quarter was down 2.4% on a year-over-year basis. During the same quarter in the previous year, the business earned $0.58 earnings per share. equities analysts expect that Acadia Healthcare will post 2.23 EPS for the current fiscal year.

COPYRIGHT VIOLATION WARNING: This piece was reported by Watch List News and is owned by of Watch List News. If you are viewing this piece on another publication, it was illegally stolen and republished in violation of U.S. and international copyright & trademark laws. The legal version of this piece can be read at https://www.watchlistnews.com/acadia-healthcare-company-inc-achc-given-average-recommendation-of-hold-by-brokerages/1682090.html.

In other Acadia Healthcare news, EVP Christopher L. Howard sold 53,713 shares of Acadia Healthcare stock in a transaction on Tuesday, August 22nd. The shares were sold at an average price of $50.69, for a total value of $2,722,711.97. Following the completion of the transaction, the executive vice president now directly owns 147,286 shares of the company’s stock, valued at approximately $7,465,927.34. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, President Brent Turner sold 206,252 shares of Acadia Healthcare stock in a transaction on Tuesday, August 22nd. The stock was sold at an average price of $50.69, for a total transaction of $10,454,913.88. Following the completion of the transaction, the president now directly owns 81,106 shares of the company’s stock, valued at $4,111,263.14. The disclosure for this sale can be found here. Over the last quarter, insiders sold 1,826,040 shares of company stock worth $92,564,008. 11.10% of the stock is currently owned by insiders.

Several large investors have recently modified their holdings of ACHC. Zurcher Kantonalbank Zurich Cantonalbank grew its stake in shares of Acadia Healthcare by 11.1% in the 2nd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 2,704 shares of the company’s stock worth $134,000 after buying an additional 270 shares in the last quarter. C M Bidwell & Associates Ltd. purchased a new position in shares of Acadia Healthcare in the 2nd quarter worth $205,000. Riverhead Capital Management LLC purchased a new position in shares of Acadia Healthcare in the 2nd quarter worth $209,000. Paloma Partners Management Co purchased a new position in shares of Acadia Healthcare in the 1st quarter worth $217,000. Finally, Rathbone Brothers plc purchased a new position in shares of Acadia Healthcare in the 3rd quarter worth $223,000.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc is a provider of behavioral healthcare services, with operations in the United States and the United Kingdom. The Company focuses on acquiring and developing behavioral healthcare facilities. The Company operates through two segments: U.S. Facilities and U.K. Facilities.

Analyst Recommendations for Acadia Healthcare (NASDAQ:ACHC)

Receive News & Ratings for Acadia Healthcare Company Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare Company Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.